No evidence for evolution of protease inhibitor resistance from standard genotyping, after three years of treatment with darunavir/ritonavir, with or without nucleoside analogues

MeSH terms

• Acquired Immunodeficiency Syndrome / drug therapy*
• Anti-HIV Agents / pharmacology*
• Darunavir
• Drug Resistance, Viral*
• Genotype
• HIV Protease Inhibitors / pharmacology*
• Humans
• Nucleosides / pharmacology
• RNA, Viral / drug effects*
• Ritonavir / pharmacology*
• Sulfonamides / pharmacology*
• Time Factors
• Viral Load